ReviewFrontiers in psychiatry2026
A taxon-centered review of bacterial shifts in psychiatric disorders.
Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gut Microbiome Dysregulation Across Schizophrenia Spectrum Disorders: Bacteria-, Fungi- and Virome-Level Alterations with Molecular and Immunological Implications.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Psychiatric conditions rank among the leading causes of disability worldwide, with their burden steadily increasing in recent years. Recent research highlights the gut-brain axis as a pivotal pathway in mental health, implicating gut microbiota shifts in conditions such as depression, anxiety, schizophrenia, bipolar disorder, autism spectrum disorder, Alzheimer's disease and others. However, most reviews remain diagnosis-centered. Methods: We conducted a structured literature review of articles published between January 2015 and July 2025 in PubMed, Scopus, and Web of Science. We included both human and animal studies that reported taxonomic changes in gut microbiota associated with psychiatric or neurodevelopmental disorders. Editorials, conference abstracts, and studies lacking full-text availability, not addressing psychiatric outcomes or specific taxonomic data were excluded. Thus, data on bacterial taxa reported as increased or decreased versus controls were extracted and reorganized into a taxon-centered database. Results: The analysis suggested distinct yet overlapping microbial alterations across psychiatric conditions. Taxa such as Conclusion: By changing the perspective from diagnosis to taxon-centered analysis, this review suggests microbial signatures that appear across psychiatric diseases, supporting the possibility of shared pathophysiological pathways. Given the largely associative nature of the available data, these findings should be interpreted cautiously and may help guide future research exploring the role of the gut microbiota in mental health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.